KAT8/SIRT7-mediated Fascin-K41 acetylation/deacetylation regulates tumor metastasis in esophageal squamous cell carcinoma
- PMID: 38411274
- DOI: 10.1002/path.6261
KAT8/SIRT7-mediated Fascin-K41 acetylation/deacetylation regulates tumor metastasis in esophageal squamous cell carcinoma
Abstract
Fascin actin-bundling protein 1 (Fascin) is highly expressed in a variety of cancers, including esophageal squamous cell carcinoma (ESCC), working as an important oncogenic protein and promoting the migration and invasion of cancer cells by bundling F-actin to facilitate the formation of filopodia and invadopodia. However, it is not clear how exactly the function of Fascin is regulated by acetylation in cancer cells. Here, in ESCC cells, the histone acetyltransferase KAT8 catalyzed Fascin lysine 41 (K41) acetylation, to inhibit Fascin-mediated F-actin bundling and the formation of filopodia and invadopodia. Furthermore, NAD-dependent protein deacetylase sirtuin (SIRT) 7-mediated deacetylation of Fascin-K41 enhances the formation of filopodia and invadopodia, which promotes the migration and invasion of ESCC cells. Clinically, the analysis of cancer and adjacent tissue samples from patients with ESCC showed that Fascin-K41 acetylation was lower in the cancer tissue of patients with lymph node metastasis than in that of patients without lymph node metastasis, and low levels of Fascin-K41 acetylation were associated with a poorer prognosis in patients with ESCC. Importantly, K41 acetylation significantly blocked NP-G2-044, one of the Fascin inhibitors currently being clinically evaluated, suggesting that NP-G2-044 may be more suitable for patients with low levels of Fascin-K41 acetylation, but not suitable for patients with high levels of Fascin-K41 acetylation. © 2024 The Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Keywords: Fascin; F‐actin; KAT8; SIRT7; acetylation; esophageal squamous cell carcinoma; filopodia; invadopodia; tumor metastasis.
© 2024 The Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
References
-
- Zhang Y, Liang B, Dong H. Expression of fascin_1 protein in cancer tissues of patients with nonsmall cell lung cancer and its relevance to patients' clinicopathologic features and prognosis. J Cancer Res Ther 2018; 14: 856–859.
-
- Son BK, Kim DH, Min KW, et al. Smad4/Fascin index is highly prognostic in patients with diffuse type EBV‐associated gastric cancer. Pathol Res Pract 2018; 214: 475–481.
-
- Liu Y, Hong W, Zhou C, et al. miR‐539 inhibits FSCN1 expression and suppresses hepatocellular carcinoma migration and invasion. Oncol Rep 2017; 37: 2593–2602.
-
- Qian CJ, Chen YY, Zhang X, et al. Notch4 inhibition reduces migration and invasion and enhances sensitivity to docetaxel by inhibiting Akt/fascin in pancreatic cancer cells. Oncol Lett 2016; 12: 3499–3505.
-
- Yu S, Xie H, Zhang J, et al. MicroRNA‐663 suppresses the proliferation and invasion of colorectal cancer cells by directly targeting FSCN1. Mol Med Rep 2017; 16: 9707–9714.
Publication types
MeSH terms
Substances
Grants and funding
- 2020LKSFG07B/2020 Li Ka Shing Foundation Cross-Disciplinary Research Grant
- 81872372/National Natural Science Foundation of China
- 82173034/National Natural Science Foundation of China
- 82273108/National Natural Science Foundation of China
- 2021KCXTD005/Innovative Team Grant of Guangdong Department of Education
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous